Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Cash Flows From Operating Activities
Loss from continuing operations	$ (35,448)	$ (97,361)	$ (71,350)
Loss from discontinued operations		(19,147)	(7,103)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	20,564	25,564	32,592
Impairment of indefinite lived intangible asset		12,200
Share-based compensation	11,313	8,216	8,458
Amortization of debt issuance costs	1,408	784	363
Accretion/(amortization) of investment premiums/discounts	1,584	295
Accretion of interest on long-term debt	5,105	4,302	3,596
Provision for bad debt	(707)	787	1,392
Provision for write-down of inventories	2,836	5,255	2,129
Loss on disposal of property and equipment	666	1,013	296
Gain on previously held equity interest in Morphormics		(662)
Loss from deconsolidation of a variable interest entity		3,442
Provision for deferred income taxes	92	947	495
Changes in assets and liabilities:
Restricted cash	(163)	(1,163)	1,605
Accounts receivable	(14,786)	10,858	(9,162)
Inventories	(8,341)	(5,147)	11,927
Prepaid expenses and other assets	(5,241)	4,382	2,523
Deferred cost of revenue	(4,875)	(4,005)	2,080
Accounts payable	(1,057)	(1,140)	(21,425)
Accrued liabilities	21,696	(18,525)	(10,538)
Customer advances	1,744	(659)	(7,044)
Deferred revenue	3,956	3,587	20,887
Net cash provided by (used in) operating activities	346	(66,177)	(38,279)
Cash Flows From Investing Activities
Purchases of property and equipment, net	(11,931)	(15,126)	(10,769)
Purchases of intangible assets		(232)
Purchases of investments	(44,155)	(102,403)
Sales and maturities of investments	64,578
Acquisition of business, net of cash acquired		(3,861)	(1,384)
Net cash provided by (used in) investing activities	8,492	(121,622)	(12,153)
Cash Flows From Financing Activities
Proceeds from issuance of common stock	9,054	7,455	4,449
Payment to the convertible note holders to modify the notes	(417)
Taxes paid related to net share settlement of equity awards	(260)
Proceeds from debt, net of costs		110,462	96,100
Net cash provided by financing activities	8,377	117,917	100,549
Effect of exchange rate changes on cash and cash equivalents	1,818	(309)	(2,519)
Net increase (decrease) in cash and cash equivalent	19,033	(70,191)	47,598
Cash and cash equivalents at beginning of period	73,313	143,504	95,906
Cash and cash equivalents at end of period	92,346	73,313	143,504
Supplemental Disclosure of Cash Flow Information
Cash paid for income taxes	2,499	2,000	1,198
Cash paid for interest	8,208	3,750	1,875
Non-cash financing activity:
Carrying amount of the equity conversion component	7,844		23,189
Purchases of property and equipment recorded in accounts payable and accrued liabilities	$ 1,142	$ 366	$ 389